Both miR-17-5p and miR-17-3p have been implicated in co-ordinately targeting the TIMP metallopeptidase inhibitor 3 (TIMP3) gene and induce growth and invasion of prostate tumour [40]. The gene discussed is TIMP3; the disease is prostate neoplasm.